← Leaderboards
Jennifer Jean Linderman
University Of Michigan At Ann Arbor
$5,379,892
Attributed
$14,570,941
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2008–19$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$14,570,941 · 6
By mechanism
R01$10,965,683 · 4
U01$2,949,071 · 1
R33$656,187 · 1
Top collaborators
- Joanne L. Flynn13 shared
- Denise E Kirschner13 shared
- Gary D Luker5 shared
- Shuichi Takayama5 shared
- Veronique Dartois4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Steven Lynn Kunkel$20,708,735
- Alon Kahana$2,583,766
- Stephen W Chensue$2,517,003
- James Michael Balter$4,444,837
- Michael Mark Alexander Sutton$6,615,102
Others in their field
Top investigators on “Computer Simulation”
- Daniel Stanzione · Arizona State University$135,429,468
- Omar N Ghattas · Carnegie Mellon University$128,934,182
- John E West · University Of Texas At Austin$110,966,494
- Kelly P Gaither · Purdue University$107,336,031
- Roger T Howe · University Of California-Berkeley$92,406,769
- Daniel C Ralph · Cornell University$89,901,072
Research focus
Computer SimulationTissuesIn VivoCessation Of LifeBaseComplexLymph NodesAnimal ModelMycobacterium TuberculosisImmune ResponseGranulomaInfectionOrganNonhuman PrimateCellsTuberculosisImageResponseEngineeringMolecularTreatment StrategyEventLungMathematical Model
Grant awards (24)
A Multi-scale systems pharmacology approach to TB therapy$717,296
U01 · FY2019 · HL
Systems Bioengineering of Cancer Cell Migration$437,470
R01 · FY2019 · CA
A Multi-scale systems pharmacology approach to TB therapy$717,122
U01 · FY2018 · HL
Systems Bioengineering of Cancer Cell Migration$449,826
R01 · FY2018 · CA
A Multi-scale systems pharmacology approach to TB therapy$714,113
U01 · FY2017 · HL
Systems Bioengineering of Cancer Cell Migration$447,397
R01 · FY2017 · CA
Predicting immune responses that correlate with protection against tuberculosis$1,149,943
R01 · FY2016 · HL
A Multi-scale systems pharmacology approach to TB therapy$800,540
U01 · FY2016 · HL
Systems Bioengineering of Cancer Cell Migration$434,360
R01 · FY2016 · CA
Predicting immune responses that correlate with protection against tuberculosis$1,141,651
R01 · FY2015 · HL
Systems Bioengineering of Cancer Cell Migration$431,856
R01 · FY2015 · CA
Predicting immune responses that correlate with protection against tuberculosis$1,211,784
R01 · FY2014 · HL
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri$573,969
R01 · FY2014 · EB
Predicting immune responses that correlate with protection against tuberculosis$1,172,751
R01 · FY2013 · HL
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri$559,666
R01 · FY2013 · EB
Predicting immune responses that correlate with protection against tuberculosis$1,252,487
R01 · FY2012 · HL
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri$595,013
R01 · FY2012 · EB
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri$610,696
R01 · FY2011 · EB
A multi-scale and multi-system approach to understand granuloma formation in TB$218,363
R33 · FY2010 · HL · contact PI
A multi-scale and multi-system approach to understand granuloma formation in TB$218,734
R33 · FY2009 · HL · contact PI
A multi-scale and multi-system approach to understand granuloma formation in TB$219,090
R33 · FY2008 · HL · contact PI
Understanding G-Protein Coupled Receptors$165,442
R01 · FY2003 · GM
Understanding G-Protein Coupled Receptors$165,442
R01 · FY2002 · GM
Understanding G-Protein Coupled Receptors$165,930
R01 · FY2001 · GM